Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...

Meta’s Orion AR glasses are still a ways off, but from what I've, I believe that they are the tech leap that could finally make AR specs the next big thing. However, recent news also has me a li ...

Celgene aims to boost the effectiveness of its novel drug marizomib for aggressive brain tumour glioblastoma (GBM) by asking patients to wear a special cap. Marketed by Novocure, the Optune ...

WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader ...

A YouTuber has recorded himself being publicly degraded by strangers on the street during a gruelling 38-hour effort to beat a world record. The streamer, who goes by the need of “Norme ...

If the Meta Orion AR glasses or Samsung and Google's Project Moohan have you intrigued about XR smart glasses in 2024 then you're in the right place. Because while you might think that following ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Oliver Sartor host Dana Rathkopf for a discussion on BMS-986365, a novel androgen receptor ligand-directed degrader for prostate cancer treatment. Amanda Nizam presents findings from the UNITE study ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.